Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?
- 1 March 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (6), 777-780
- https://doi.org/10.1016/0006-2952(85)90757-9
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Roles of thymidylate synthetase activity in herpes simplex virus-infected HeLa cellsBiochemical Pharmacology, 1983
- Characterization of Ribonucleotide Reductase Induction in BHK-21/C13 Syrian Hamster Cell Line Upon Infection by Herpes Simplex Virus (HSV)Journal of General Virology, 1981
- Anti-herpes simplex virus and anti-human cell growth activity of E-5-propenyl-2'-deoxyuridine and the concept of selective protection in antivirus chemotherapyAntimicrobial Agents and Chemotherapy, 1980
- An enzymatic method for distinguishing deoxyuridine and deoxythymidine nucleotide pools and its application for determining ribonucleotide reductase activityJournal of Biochemical and Biophysical Methods, 1979
- Ribonucleotide reductase isolated from human cellsBiochemical Pharmacology, 1978
- Deoxyribonucleotide metabolism in herpes simplex virus infected HeLa cellsBiochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis, 1975
- A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and virusesNature, 1975
- A rapid assay for CDP reductase activity in mammalian cell extractsAnalytical Biochemistry, 1970
- Deoxyrbionucleic acid nucleotidyltransferase and deoxyribonuclease from cultured cells infected with herpes simplex virusBiochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects, 1963
- Acquisition of thymidine kinase activity by herpes simplex infected mouse fibroblast cellsBiochemical and Biophysical Research Communications, 1963